Home/ Stocks/ RGC

Regencell Bioscience Holdings Limited Ordinary Shares

RGC XNAS

$5.66 +0.61 (+12.08%) ▲ 15-min delayed

Open

$5.11

High

$5.72

Low

$4.93

Volume

381.4K

Market Cap

$2.50B

About Regencell Bioscience Holdings Limited Ordinary Shares

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Employees: 10 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2017	$3.16B	$112.30M	$0.72
FY 2017	$3.16B	$112.30M	$0.72
Q3 2017	$716.00M	$11.40M	$0.07
Q2 2017	$764.20M	$23.60M	$0.15

TickerDaily Coverage

Why Is Regencell Bioscience Holdings Limited Ordinary Shares (RGC) Stock Up 42.3% Today?

Market News Alex Chen · Apr 1, 2026

Regencell Bioscience Holdings Limited (RGC) stock exploded 42.3% higher Wednesday, April 1, 2026,...

View All Coverage →

Get RGC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Regencell Bioscience Holdings Limited Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.